Status:
COMPLETED
Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery
Lead Sponsor:
San Gerardo Hospital
Collaborating Sponsors:
A.O. Ospedale Papa Giovanni XXIII
Conditions:
Ovarian Cysts
Eligibility:
FEMALE
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg may prevent the use of morphine during the first day after laparoscopic ovarian cyst surgery.
Detailed Description
In a recent study the investigators found that nebulization of Ropivacaine 30 mg before or after gynaecologic laparoscopic surgery significantly reduces postoperative pain and postoperative morphine c...
Eligibility Criteria
Inclusion
- Females 18-65 years old
- ASA Score I-III
- Scheduled for ovarian cyst laparoscopic surgery
- Free from pain in preoperative period
- Not using analgesic drugs before surgery
- Without cognitive impairment or mental retardation
- Written informed consent
Exclusion
- Emergency/urgency surgery
- Postoperative admission in an intensive care unit
- Cognitive impairment or mental retardation
- Progressive degenerative diseases of the CNS
- Seizures or chronic therapy with antiepileptic drugs
- Severe hepatic or renal impairment
- Pregnancy or lactation
- Allergy to one of the specific drugs under study
- Acute infection or inflammatory chronic disease
- Alcohol or drug addiction
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01142622
Start Date
April 1 2010
End Date
December 1 2012
Last Update
February 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Gerardo Hospital
Monza, MB, Italy, 20052